CADRENAL THERAPEUTICS, INC. (CVKD)
Cadrenal Therapeutics Advances Multi-Indication Strategy for CAD-1005; Launches Phase 2a Acute Kidney Injury (CSA-AKI) Clinical Plan to Accelerate Pharma Partnering at Upcoming BIO 2026
Cadrenal Therapeutics Advances Multi-Indication Strategy for CAD-1005; Launches Phase 2a Acute Kidney Injury (CSA-AKI) Clinical Plan to Accelerate Pharma Partnering at Upcoming BIO 2026
Alto Ingredients, Inc. Completes Transaction to Monetize All 2025 45Z Clean Fuel Production Tax Credits
Splash Beverage Group Invests in Avicanna, a Leading Cannabinoid Biopharmaceutical Platform, Advancing Its Transformation Into Cannabinoid Healthcare
Aeries Technology Secures Strategic GCC Advisory Mandate with Leading Global Tax and Financial Advisory Platform
Bond CEO to Host Investor Webinar on New Developments Reinforcing Accelerating Demand
HyOrc Corporation Secures Financing for Initial Module of 35 TPD Portuguese Waste-to-Methanol Facility
Shikun & Binui Energy is not proceeding with handling Keystone’s offer to purchase its shares, continued
The company is not advancing the handling of Keystone’s proposal to purchase its shares, continued
VICI Properties and Club Med Announce Acquisition and Redevelopment of Carambola Beach Resort in St. Croix
SLB Launches Digital Marketplace to Scale AI and Digital Innovation Across Energy